Guyasuta Investment Advisors Inc. Has $21.67 Million Stake in Thermo Fisher Scientific Inc (TMO)

Guyasuta Investment Advisors Inc. reduced its stake in Thermo Fisher Scientific Inc (NYSE:TMO) by 0.8% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 124,202 shares of the medical research company’s stock after selling 971 shares during the period. Thermo Fisher Scientific makes up about 2.6% of Guyasuta Investment Advisors Inc.’s holdings, making the stock its 15th largest holding. Guyasuta Investment Advisors Inc.’s holdings in Thermo Fisher Scientific were worth $21,670,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors also recently bought and sold shares of the company. Atlantic Trust Group LLC boosted its holdings in shares of Thermo Fisher Scientific by 0.3% in the second quarter. Atlantic Trust Group LLC now owns 565,848 shares of the medical research company’s stock worth $98,723,000 after acquiring an additional 1,472 shares during the period. Meiji Yasuda Life Insurance Co boosted its holdings in shares of Thermo Fisher Scientific by 0.4% in the second quarter. Meiji Yasuda Life Insurance Co now owns 23,256 shares of the medical research company’s stock worth $4,057,000 after acquiring an additional 100 shares during the period. Baltimore Capital Management Inc. bought a new position in shares of Thermo Fisher Scientific in the second quarter worth $209,000. Rosenblum Silverman Sutton S F Inc. CA boosted its holdings in shares of Thermo Fisher Scientific by 0.3% in the second quarter. Rosenblum Silverman Sutton S F Inc. CA now owns 43,958 shares of the medical research company’s stock worth $7,669,000 after acquiring an additional 145 shares during the period. Finally, Synovus Financial Corp boosted its holdings in shares of Thermo Fisher Scientific by 37.3% in the second quarter. Synovus Financial Corp now owns 3,470 shares of the medical research company’s stock worth $603,000 after acquiring an additional 943 shares during the period. 83.36% of the stock is owned by hedge funds and other institutional investors.

Shares of Thermo Fisher Scientific Inc (TMO) opened at 193.39 on Friday. Thermo Fisher Scientific Inc has a 52-week low of $139.07 and a 52-week high of $194.30. The firm’s 50-day moving average price is $188.78 and its 200-day moving average price is $174.98. The stock has a market cap of $75.45 billion, a P/E ratio of 33.69 and a beta of 1.05.

Thermo Fisher Scientific (NYSE:TMO) last announced its quarterly earnings results on Wednesday, July 26th. The medical research company reported $2.30 EPS for the quarter, topping the consensus estimate of $2.27 by $0.03. The business had revenue of $5 billion for the quarter, compared to analysts’ expectations of $4.92 billion. Thermo Fisher Scientific had a net margin of 11.80% and a return on equity of 15.97%. The business’s quarterly revenue was up 10.2% compared to the same quarter last year. During the same quarter in the previous year, the company earned $2.03 EPS. Equities analysts predict that Thermo Fisher Scientific Inc will post $9.35 EPS for the current year.

In other Thermo Fisher Scientific news, Director C Martin Harris sold 360 shares of the business’s stock in a transaction on Wednesday, August 30th. The shares were sold at an average price of $180.97, for a total value of $65,149.20. Following the sale, the director now owns 5,312 shares in the company, valued at approximately $961,312.64. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Jim P. Manzi sold 11,318 shares of the business’s stock in a transaction on Friday, August 18th. The stock was sold at an average price of $172.94, for a total transaction of $1,957,334.92. Following the completion of the sale, the director now owns 38,757 shares in the company, valued at approximately $6,702,635.58. The disclosure for this sale can be found here. In the last quarter, insiders sold 52,738 shares of company stock worth $9,302,112. Corporate insiders own 0.49% of the company’s stock.

COPYRIGHT VIOLATION WARNING: “Guyasuta Investment Advisors Inc. Has $21.67 Million Stake in Thermo Fisher Scientific Inc (TMO)” was originally reported by Community Financial News and is the property of of Community Financial News. If you are viewing this report on another domain, it was illegally copied and republished in violation of U.S. & international trademark & copyright law. The legal version of this report can be read at https://www.com-unik.info/2017/10/13/guyasuta-investment-advisors-inc-has-21-67-million-stake-in-thermo-fisher-scientific-inc-tmo.html.

TMO has been the subject of a number of analyst reports. Zacks Investment Research raised Thermo Fisher Scientific from a “hold” rating to a “buy” rating and set a $208.00 price target for the company in a report on Thursday, September 7th. Morgan Stanley reiterated an “overweight” rating and issued a $220.00 price objective on shares of Thermo Fisher Scientific in a research report on Wednesday, September 6th. Cowen and Company reiterated an “outperform” rating and issued a $220.00 price objective (up previously from $200.00) on shares of Thermo Fisher Scientific in a research report on Sunday, September 10th. Cleveland Research upgraded Thermo Fisher Scientific from a “neutral” rating to a “buy” rating in a research report on Thursday, July 20th. Finally, Bank of America Corporation reiterated a “buy” rating and issued a $210.00 price objective (up previously from $200.00) on shares of Thermo Fisher Scientific in a research report on Friday, July 21st. One equities research analyst has rated the stock with a hold rating and sixteen have assigned a buy rating to the company. The company presently has an average rating of “Buy” and a consensus price target of $203.64.

Thermo Fisher Scientific Company Profile

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

What are top analysts saying about Thermo Fisher Scientific Inc? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Thermo Fisher Scientific Inc and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit